Warby Parker Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Eyewear Products at $198.1 million, 81% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
935
|
245
|
236
|
242
|
212
|
222
|
214
|
224
|
191
|
| Eyewear Products |
—
|
198
+9.0%
share 80.9%
|
192
+8.4%
share 81.4%
|
201
+7.2%
share 83.1%
|
99
-48.6%
share 46.9%
|
182
share 82.0%
|
177
share 82.5%
|
188
share 83.9%
|
194
share 101.6%
|
| Contacts |
—
|
28
+9.4%
share 11.4%
|
27
+7.9%
share 11.3%
|
24
+5.2%
share 10.0%
|
—
|
26
share 11.5%
|
25
share 11.5%
|
23
share 10.3%
|
—
|
| Eye Care |
—
|
19
+29.7%
share 7.7%
|
17
+32.2%
share 7.3%
|
17
+30.0%
share 6.9%
|
15
+617.5%
share 7.2%
|
14
share 6.5%
|
13
share 6.0%
|
13
share 5.8%
|
-3
share -1.6%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- WRBY (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1504776
- Former names
- JAND, Inc. (until Mar 23, 2018)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- National Vision Holdings, Inc. EYE
- Staar Surgical Co STAA
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.